A Study to Assess the Safety of a New Inserter Device for Paragard® (Intrauterine Copper Contraceptive)

The purpose of this study is to demonstrate that a new device inserter leads to successful and safe insertion of Paragard® IUS, comparable to the currently approved IUS inserter, in females of reproductive potential.

Inclusion Criteria: * Subject is a postmenarcheal and premenopausal woman of child bearing potential. * Subjects are at least 18 years of age, at the time of signing the informed consent. * Subject is overtly healthy as determined by medical evaluation. Exclusion Criteria: * Pregnancy or suspicion of pregnancy or at risk for luteal phase pregnancy * History of previous IUD complications * Abnormalities of the uterus resulting in distortion of the uterine cavity that may complicate IUD insertion * Known anatomical abnormalities of the cervix * Presence of acute pelvic inflammatory disease at the time of screening. * Postpartum endometritis. * Known or suspected uterine or cervical malignancy. * Uterine bleeding of unknown etiology. * Untreated acute cervicitis or vaginitis or other lower genital tract infection. * Conditions associated with increased susceptibility to pelvic infections. * Subjects with Wilson's disease.